查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
奈米技术在癌症治疗的应用：科技与全球市场
市场调查报告书
商品编码
1708114

奈米技术在癌症治疗的应用：科技与全球市场

Nanotechnology in Cancer Treatment: Technologies and Global Markets
出版日期: | 出版商: BCC Research | 英文 107 Pages | 订单完成后即时交付

价格

本报告调查了癌症治疗中的奈米技术市场，并提供了市场概况摘要、市场影响因素和市场机会分析、法律制度、新兴技术和技术发展趋势、市场规模趋势和预测、各个细分市场和地区的详细分析、竞争格局以及主要企业的概况。

目录

第一章执行摘要

  • 市场展望
  • 研究范围
  • 市场摘要

第二章 市场概述

  • 概述
  • 专利分析
  • 波特五力分析
  • 未来展望

第三章 市场动态

  • 市场动态
  • 市场驱动因素
  • 全球癌症发生率不断上升
  • 增加政府经费和医药品研究开发费用
  • 奈米粒子在癌症治疗的优势
  • 利用奈米材料精准标靶化癌细胞
  • 市场限制
  • 奈米粒子临床应用的障碍
  • 肿瘤科专家短缺
  • 市场机会
  • 奈米粒子克服抗药性的机制
  • 癌症蛋白质体学

第四章 监管情况

  • 概述
  • 美国
  • 欧洲
  • 日本

第五章 新兴科技与新发展

  • 新兴趋势和技术
  • AI
  • 量子点
  • 肿瘤学产品平臺

第六章 市场区隔分析

  • 细分市场
  • 按产品类型进行市场分析
  • 全球市场规模及预测
  • 脂质体
  • 聚合物奈米粒子
  • 胶束
  • 水凝胶
  • 树状聚合物
  • 市场分析：按癌症类型
  • 全球市场规模及预测
  • 肺癌
  • 乳癌
  • 白血病
  • 淋巴瘤
  • 黑色素瘤
  • 其他的
  • 地理分布
  • 市场分析：按地区
  • 全球市场规模及预测
  • 北美洲
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 南美洲

第七章 竞争讯息

  • 概述
  • 竞争格局

第 8 章 附录

  • 调查方法
  • 简称
  • 来源
  • 公司简介
  • ASTRAZENECA
  • BAXTER
  • BOSTON SCIENTIFIC CORP.
  • BRISTOL-MYERS SQUIBB CO.
  • F. HOFFMANN-LA ROCHE LTD.
  • JAZZ PHARMACEUTICALS INC.
  • LES LABORATOIRES SERVIER
  • NOVARTIS AG
  • PFIZER INC.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • 其他新兴企业
Product Code: PHM222B

The report provides an analysis of the global market for nanotechnology in cancer treatment. Using 2023 as the base year, the report provides estimated market data for 2024 through 2029. The market in this report is segmented into product type, cancer type, and region. The report concludes with profiles of the major players in the market.

Report Scope

This report provides detailed information about nanotechnology in the cancer treatment market. The report analyzes the market trends for nanotechnology in cancer treatment with data from 2023, estimates from 2024, projections of compound annual growth rates through 2029 (forecast period 2024-2029), and regional markets. This report highlights nanotechnology in cancer treatment's current and future market potential and analyzes the competitive environment. The report covers regulatory scenarios, drivers, restraints and opportunities. The report also covers market estimates for 2029 and market shares for key players.

The market scope in this report is segmented into product type and cancer types. Based on product type, the market is segmented into liposomes, polymeric nanoparticles, micelles, hydrogels, and dendrimers. The market is segmented by cancer type into lungs, breast, leukemia, lymphoma, melanoma and other cancers.

The market has been segmented into the following regions: North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The regional segment includes a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia and India. For market projections, data will be provided for 2023 as the base year, with forecasts for 2024 through 2029.

The report's goals include:

  • Analyzing product and cancer type.
  • Analyzing global market size and segments.
  • Reviewing market constraints and drivers.
  • Providing detailed market forecasts for 2029.
  • Assessing market shares, competitiveness and industry structure.
  • Identifying potential long-term impacts on nanotechnology in the cancer treatment market.

Report Includes

  • Analyses of the trends in global markets for nanotechnology in cancer treatment, with revenue data for 2022 to 2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
  • Estimates of the size and revenue prospects for the global market, along with a market share analysis by product type, application and region
  • Facts and figures pertaining to the global market dynamics, technological advances, regulations and standards, and the impact of macroeconomic factors
  • Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
  • Information pertaining to evolving trends and patterns, recent technological breakthroughs, and the types of nanostructured materials, nanodevices, and nanotools used for research, diagnosis and therapy of the types of cancer
  • Statistics regarding the incidence and prevalence of cancer cases, as well as global mortality figures
  • Analysis of relevant patents and patent grants
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Profiles of leading companies

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • Patent Analysis
  • Analysis of Porter's Five Forces
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Potential for New Entrants
  • Threat of Substitutes
  • Competitiveness in the Industry
  • Future Perspective

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Increasing Prevalence of Cancer Cases Globally
  • Rise in Government Funding and Pharmaceutical R&D Spending
  • Nanoparticles in Cancer Treatment: Advantages
  • Precision Targeting of Cancer Cells with Nanomaterials
  • Market Restraints
  • Roadblocks to Clinical Nanoparticle Use
  • Lack of Oncology Professionals
  • Market Opportunities
  • Mechanism of Nanoparticles in Overcoming Drug Resistance
  • Cancer Proteomics

Chapter 4 Regulatory Landscape

  • Overview
  • U.S.
  • Europe
  • Japan

Chapter 5 Emerging Technologies and New Developments

  • Emerging Trends and Technologies
  • Artificial Intelligence
  • Quantum Dots
  • Oncology Products Pipeline

Chapter 6 Market Segment Analysis

  • Segmentation Breakdown
  • Market Analysis by Product Type
  • Global Market Size and Forecast
  • Liposomes
  • Polymeric Nanoparticles
  • Micelles
  • Hydrogels
  • Dendrimers
  • Market Analysis by Cancer Type
  • Global Market Size and Forecast
  • Lung Cancer
  • Breast Cancer
  • Leukemia
  • Lymphoma
  • Melanoma
  • Other Cancers
  • Geographic Breakdown
  • Market Analysis by Region
  • Global Market Size and Forecast
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America

Chapter 7 Competitive Intelligence

  • Overview
  • Competitive Landscape

Chapter 8 Appendix

  • Methodology
  • Abbreviations
  • Sources
  • Company Profiles
  • ASTRAZENECA
  • BAXTER
  • BOSTON SCIENTIFIC CORP.
  • BRISTOL-MYERS SQUIBB CO.
  • F. HOFFMANN-LA ROCHE LTD.
  • JAZZ PHARMACEUTICALS INC.
  • LES LABORATOIRES SERVIER
  • NOVARTIS AG
  • PFIZER INC.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • Other Emerging Players

List of Tables

  • Summary Table : Global Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
  • Table 1 : Select Patent Grants on Nanotechnology in Cancer Treatment, 2024 and 2025
  • Table 2 : Porter's Five Forces Analysis: Nanotechnology in Cancer Treatment Market
  • Table 3 : Selected Clinical Trials Studies on Nanotechnology in Cancer Treatment, 2024
  • Table 4 : Global Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
  • Table 5 : Global Market for Nanotechnology-based Liposomes in Cancer Treatment, by Region, Through 2029
  • Table 6 : Global Market for Nanotechnology-based Polymeric Nanoparticles in Cancer Treatment, by Region, Through 2029
  • Table 7 : Global Market for Nanotechnology-based Micelles in Cancer Treatment, by Region, Through 2029
  • Table 8 : Global Market for Nanotechnology-based Hydrogels in Cancer Treatment, by Region, Through 2029
  • Table 9 : Global Market for Nanotechnology-based Dendrimers in Cancer Treatment, by Region, Through 2029
  • Table 10 : Global Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
  • Table 11 : Global Market for Nanotechnology in Lung Cancer Treatment, by Region, Through 2029
  • Table 12 : Global Market for Nanotechnology in Breast Cancer Treatment, by Region, Through 2029
  • Table 13 : Global Market for Nanotechnology in Leukemia Cancer Treatment, by Region, Through 2029
  • Table 14 : Global Market for Nanotechnology in Lymphoma, by Region, Through 2029
  • Table 15 : Global Market for Nanotechnology in Melanoma Treatment, by Region, Through 2029
  • Table 16 : Global Market for Nanotechnology in Other Cancers, by Region, Through 2029
  • Table 17 : Global Market for Nanotechnology in Cancer Treatment, by Region, Through 2029
  • Table 18 : North American Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
  • Table 19 : North American Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
  • Table 20 : North American Market for Nanotechnology in Cancer Treatment, by Country, Through 2029
  • Table 21 : European Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
  • Table 22 : European Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
  • Table 23 : European Market for Nanotechnology in Cancer Treatment, by Country, Through 2029
  • Table 24 : Asia-Pacific Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
  • Table 25 : Asia-Pacific Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
  • Table 26 : Asia-Pacific Market for Nanotechnology in Cancer Treatment, by Country, Through 2029
  • Table 27 : Middle East and African Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
  • Table 28 : Middle East and African Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
  • Table 29 : South American Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
  • Table 30 : South American Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
  • Table 31 : Major Market Players in Nanotechnology in Cancer Treatment, 2023
  • Table 32 : Abbreviations Used in this Report
  • Table 33 : Information Sources in this Report
  • Table 34 : AstraZeneca: Company Snapshot
  • Table 35 : AstraZeneca: Financial Performance, FY 2022 and 2023
  • Table 36 : AstraZeneca: Product Portfolio
  • Table 37 : AstraZeneca: News/Key Developments, 2023 and 2024
  • Table 38 : Baxter: Company Snapshot
  • Table 39 : Baxter: Financial Performance, FY 2022 and 2023
  • Table 40 : Baxter: Product Portfolio
  • Table 41 : Baxter: News/Key Developments, 2021
  • Table 42 : Boston Scientific Corp.: Company Snapshot
  • Table 43 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
  • Table 44 : Boston Scientific Corp.: Product Portfolio
  • Table 45 : Boston Scientific Corp.: News/Key Developments, 2021
  • Table 46 : Bristol-Myers Squibb Co.: Company Snapshot
  • Table 47 : Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
  • Table 48 : Bristol-Myers Squibb Co.: Product Portfolio
  • Table 49 : F. Hoffmann-La Roche Ltd.: Company Snapshot
  • Table 50 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
  • Table 51 : F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 52 : Jazz Pharmaceuticals Inc.: Company Snapshot
  • Table 53 : Jazz Pharmaceuticals Inc.: Financial Performance, FY 2022 and 2023
  • Table 54 : Jazz Pharmaceuticals Inc.: Product Portfolio
  • Table 55 : Les Laboratoires Servier: Company Snapshot
  • Table 56 : Les Laboratoires Servier: Financial Performance, FY 2022 and 2023
  • Table 57 : Les Laboratoires Servier: Product Portfolio
  • Table 58 : Les Laboratoires Servier: News/Key Developments, 2023 and 2024
  • Table 59 : Novartis AG: Company Snapshot
  • Table 60 : Novartis AG: Financial Performance, FY 2022 and 2023
  • Table 61 : Novartis AG: Product Portfolio
  • Table 62 : Pfizer Inc.: Company Snapshot
  • Table 63 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
  • Table 64 : Pfizer Inc.: Product Portfolio
  • Table 65 : Pfizer Inc.: News/Key Developments, 2023
  • Table 66 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
  • Table 67 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
  • Table 68 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
  • Table 69 : Few Emerging Players in Nanotechnology in Cancer Treatment Market

List of Figures

  • Summary Figure : Global Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
  • Figure 1 : Market Dynamics of Nanotechnology in Cancer Treatment
  • Figure 2 : Breakdown of Most Frequent Cancers in Women, by Type, 2022
  • Figure 3 : Breakdown of Most Frequent Cancers in Men, by Type, 2022
  • Figure 4 : Estimated Cancer Incidence and Mortality Cases Globally, by Cancer Type, 2024
  • Figure 5 : Trends in NCI Funding for Cancer Research, by Year, 2012-2019
  • Figure 6 : Global Pharmaceutical R&D Spending, 2020-2026
  • Figure 7 : Global Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
  • Figure 8 : Global Market Shares of Nanotechnology-based Liposomes in Cancer Treatment, by Region, 2023
  • Figure 9 : Global Market Shares of Nanotechnology-based Polymeric Nanoparticles in Cancer Treatment, by Region, 2023
  • Figure 10 : Global Market Shares of Nanotechnology-based Micelles in Cancer Treatment, by Region, 2023
  • Figure 11 : Global Market Shares of Nanotechnology-based Hydrogels in Cancer Treatment, by Region, 2023
  • Figure 12 : Global Market Shares of Nanotechnology-based Dendrimers in Cancer Treatment, by Region, 2023
  • Figure 13 : Global Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
  • Figure 14 : Global Market Shares of Nanotechnology in Lung Cancer Treatment, by Region, 2023
  • Figure 15 : Global Market Shares of Nanotechnology in Breast Cancer Treatment, by Region, 2023
  • Figure 16 : Global Market Shares of Nanotechnology in Leukemia Cancer Treatment, by Region, 2023
  • Figure 17 : Global Market Shares of Nanotechnology in Lymphoma, by Region, 2023
  • Figure 18 : Global Market Shares of Nanotechnology in Melanoma Treatment, by Region, 2023
  • Figure 19 : Global Market Shares of Nanotechnology in Other Cancers, by Region, 2023
  • Figure 20 : Global Market Shares of Nanotechnology in Cancer Treatment, by Region, 2023
  • Figure 21 : North American Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
  • Figure 22 : North American Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
  • Figure 23 : North American Market Shares of Nanotechnology in Cancer Treatment, by Country, 2023
  • Figure 24 : European Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
  • Figure 25 : European Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
  • Figure 26 : European Market Shares of Nanotechnology in Cancer Treatment, by Country, 2023
  • Figure 27 : Asia-Pacific Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
  • Figure 28 : Asia-Pacific Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
  • Figure 29 : Asia-Pacific Market Shares of Nanotechnology in Cancer Treatment, by Country, 2023
  • Figure 30 : Middle East and African Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
  • Figure 31 : Middle East and African Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
  • Figure 32 : South American Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
  • Figure 33 : South American Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
  • Figure 34 : AstraZeneca: Revenue Share, by Business Unit, FY 2023
  • Figure 35 : AstraZeneca: Revenue Share, by Country/Region, FY 2023
  • Figure 36 : Baxter: Revenue Share, by Business Unit, FY 2023
  • Figure 37 : Baxter: Revenue Share, by Country/Region, FY 2023
  • Figure 38 : Boston Scientific Corp.: Revenue Shares, by Business Unit, FY 2023
  • Figure 39 : Boston Scientific Corp.: Revenue Shares, by Country/Region, FY 2023
  • Figure 40 : Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2023
  • Figure 41 : Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
  • Figure 42 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
  • Figure 43 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
  • Figure 44 : Jazz Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 45 : Jazz Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 46 : Les Laboratoires Servier: Revenue Share, by Business Unit, FY 2023
  • Figure 47 : Les Laboratoires Servier: Revenue Share, by Region, FY 2023
  • Figure 48 : Novartis AG: Revenue Share, by Business Unit, FY 2023
  • Figure 49 : Novartis AG: Revenue Share, by Country/Region, FY 2023
  • Figure 50 : Pfizer Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 51 : Pfizer Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 52 : Teva Pharmaceutical Industries Ltd.: Market Share, by Business Unit, FY 2023
  • Figure 53 : Teva Pharmaceutical Industries Ltd.: Market Share, by Region, FY 2023